Archive for the ‘vaccines’ Category

Merck Accused of Fraud, Deceit and Negligence in U.S. Gardasil Case

http://www.greenmedinfo.com/blog/merck-accused-fraud-deceit-and-negligence-us-gardasil-case

This article is copyrighted by GreenMedInfo LLC, 2018

Merck’s aggressive agenda to increase HPV vaccine uptake rates, despite causing thousands of severe injuries, is hitting a stumbling block in a court case alleging blatant corruption.

There has been documented evidence that the HPV vaccine has caused more injuries than any other vaccination in history. Despite this evidence however, the HPV vaccination has continued to be hailed a success by the pharmaceutical industry and governments alike.

According to the World Health Organisation’s (WHO) VigiAccess database, as of April 09, 2018, a total of 85,329 reports of adverse reactions have been filed regarding the HPV vaccination. These reports include 37,699 reports of nervous system disorders; 2450 cardiac disorders, (including 38 cardiac arrests) 533 reports of Postural orthostatic tachycardia syndrome (POTS); over 3200 reports of seizures or epilepsy, 8453 syncope and 389 deaths.

In July 2016, a case was filed in the Superior Court of the State of California, Los Angeles County (central district). The case involved a 16-year-old female who between 2010 and 2011 received three injections of Gardasil, the HPV vaccination manufactured by Merck. Shortly after she received her third vaccination, she suffered a severe adverse reaction, the nature and complexity of which, failed to be diagnosed until 2015, when she finally received the diagnosis of Postural orthostatic tachycardia syndrome (POTS).

For those of you who are unaware, Postural tachycardia syndrome (POTS) is an abnormal response of your body when you are upright (usually when standing). It is caused by a problem with the nervous system which controls the autonomic functions in the body. This part of the nervous system is called the autonomic nervous system.

The symptoms of POTS occur when you are upright and are relieved when lying down. These symptoms are associated with an abnormally high and persistent increase in heart rate within ten minutes of standing.

(Description of POTS taken from Patient Access website)

If this diagnosis was not devastating enough for this young lady and her family, in 2016, she was further diagnosed with an underlying small fiber neuropathy, existing within and throughout her body.

Her family firmly now believe that the vaccinations caused her illness because prior to receiving the HPV vaccination, she was physically active, and had not only participated in her high school basketball team but had also engaged in other athletic activities.

It is for this reason, that the family decided to file a case against the manufacturer of the vaccine, Merck, accusing them of:

1. Fraud and Deceit

2. Negligent Misrepresentation

3. Defective Product – Inadequate warnings & information

4. Medical Malpractice

5. Medical Battery

As you can see these charges are extremely serious and if won, this case would set a precedent for similar cases to be brought against the manufacturer of this vaccine in the future.

Merck Accused of Fast Tracking a Vaccine for Financial Gain

The complaint outlined the fact that the Plaintiff and her family believed that Merck had wrongfully and deceitfully failed to perform in the preapproval processing period and thereafter, the material scientific and medical investigations and studies relating to the safety, effectiveness and need for the Gardasil vaccine as required by and under the FDA directives and regulations.

It is a well-known fact, that all pharmaceutical products must undergo extensive pre-marketing clinical trials often spanning several years before the FDA can consider the product for licensing.

The complaint written by the family’s attorney stated that:

“Upon approval by the FDA of the Gardasil vaccine, Defendants Merck, Does 1 through 25, and each of themcommenced and engaged in highly extensive, and aggressive marketing practices, which were designed primarily, if not solely, to increase the sales and profits from Gardasil. In doing so, Defendants Merck, Does 1 through 25, and each of them, in order to preclude any and all questions by consumers, patients and others, as to the effectiveness, safety and need for the administration of the Gardasil vaccination as well as the risks of serious adverse reaction related thereto, intentionally, wrongfully and deceitfully withheld, failed to provide and concealed from consumers, patients and others material facts and information with respect to the effectiveness, safety and need for the administration of the Gardasil vaccination, as well as the risks of serious adverse reaction related thereto and as in part hereafter set forth.” (own emphasis)

The complaint continued by describing each and every misdemeanour that Merck was thought to have participated in. It stated:

“Further, Defendants Merck and Does 1through 25 in its Marketing wrongfully and deceitfully failed to unambiguously inform those to whom the marketing was directed, of material facts and information which they knew or should have ascertained through their investigations and studies specific to risk/ benefit and quantitative risk assessments regarding and including, among other things, the following:

1. The five-year period that the Gardasil vaccine was then only known to be effective;

2. That Gardasil was effective only as to certain and not other strains of the HPV virus;

3. The Gardasil vaccine is not effective once an individual is infected with the HPV virus;

4. Other existing methods that are effective in avoiding HPV viral infections;

5. The minimal risk that even once the individual was infected with the HPV virus the infection would result in precancerous lesions;

6. The successfulness of exiting methods of diagnosing and treating HPV precancerous lesions;

7. The successfulness of exiting methods of diagnosing and treating any resulting cancer;

8. The nature as the consequences of serious adverse reactions to the HPV vaccine; and

9. Other items related and material to risk/benefit and quantitative risk assessments not now known and if required leave of Court will be requested to amend this complaint to set forth fully such item or items when ascertained

Such information was and is reasonably required by patients and consumers as well as others when considering and deciding whether or not under their individual and personal circumstances to be vaccinated with Gardasil.”

Not only did the family and their attorney outline an excellent and well thought out case, they went one step further and suggested that the court hold a Science Day Hearing.

So, what did both sides offer in the way of science to support their case and did the Judge agree to his unusual request?

Judge Agreed to a Science Day Hearing

In an unusual step the Judge in this case, agreed to hold a “Science Day Hearing” to enable the court to could get a better understanding of the science behind the HPV vaccine. In advance of the scheduled science day presentation both parties submitted briefs that outlined their side’s view of HPV vaccine science.

In other words, for the first time ever, both sides including the vaccines manufacturer Merck, were given the unique opportunity to present to the court, their up-to-date science and studies proving the safety and effectiveness of this vaccine. The information provided would prove once and for all, whether or not Gardasil was not only a safe vaccination but necessary in the fight against cancers caused by the HPV virus.

What Science Did the Two Sides Present?

The paperwork that was submitted clearly demonstrated many of the issues surrounding HPV vaccines and vaccination policies. The Plaintiff’s submission, offered clear precise facts to enable the Judge to understand the science behind the vaccination.

Their submission contained the following information:

“There are approximately 130 strains of the HPV virus, of which only 15 to 18 strains are known to be associated with cervical cancer. The Gardasil vaccine provides protection against only 4 specific strains, namely HPV 6, 11, 16 and 18. Strains 16 and 18 are thought to be casually associated with 70 % of the worldwide HPV related cervical cancers. HPV 6 & 11 are associated with warts.

As stated, ninety-five (95%) percent of HPV infections are removed from the body by its own immune and related processes without medical or other consequences. Any abnormal cell growth associated with the remaining 5%, approximately 20% (1% of the total), if not identified and removed could be at risk of developing into cancerous cells in approximately 5 years which could progress to irreversible cancer in 15 to 30 years. The incidence of cervical cancer occurring in the United States is estimated to be 1.4 to 2.3 per 100,000. The risk of precancerous cells, due to the presence of the HPV 16 and 18 viruses, progressing to cervical cancer is estimated at 1.5 per 100,000. The actual incidence rate of serious adverse events after HPV vaccination is unknown.”

They outlined a brief history of the immune system and how it works and continued by describing the nature of the autoimmune diseases that the injured teenager was now suffering from.

To support their argument, they included a wide range of scientific studies that had been written by some of the world’s leading experts and they criticized Merck for ‘misleading the public’ in their advertising campaign.

They stated that:

“Initially, qGardasil is not a treatment process and does not prevent cancer as marketed by Merck. Gardasil is a vaccine designed to increase the response of the Human Immune system to pathogens namely HPV viruses 6, 11, 16 & 18.”

They continued:

“Generally, with vaccines an adjuvant is required to be injected as a part of the vaccine to increase the body’s immune response to the antigen (disease causing organism). The most commonly used adjuvants for many years have been aluminum salts with an Aluminum hydroxide base.

It is medically and scientifically accepted that aluminum salts are toxic to and damage the human cells at the injection site. In addition, the aluminum salts cause inflammation at the site. These aluminum salts may bind with the free DNA released from the damaged and dying cells at the injection site. The combination of the Aluminum salt bound by the human DNA is effective in activating Toll Like Receptors (“TLR”), whose function in the immune system is highly complex.”

Their submission concluded that:

“The foregoing is merely illustrative of the complex and extensive scientific factors involved in this litigation. Although the purpose of Science Day it to provide the Court with information as to the nature and extent of the complex scientific matters involved, it is necessary to connect these matters to a foundation rooted in the facts of the case before the Court, which may be construed as argument.

Scientific issues not addressed in this Brief, which are relevant to the safety, efficacy/effectiveness, need and risk/benefits of qGardasil include, without limitations, the following:

1. Fast tracking of the FDA approval process to a 6-month period when criteria for fast tracking were not met.

2. Five-year effectiveness of qGardasil as of 1/1/2011, now believed to be 8 years.

3. Use of end points which did not establish the effectiveness of qGardasil.

4. Effect on the clinical trial analysis of the removal of participants experiencing adverse and serious adverse events.

5. The effect of non – HPV 16 and 18 cancer producing strains on cervical cancer occurrence when HPV 16 and 18 are eliminated.

6. Lack of adequate pediatric clinical testing of the qGardasil regarding potential ovarian disorders/failures.

7. The effect of clinical testing and studies involving undeveloped countries on U.S. analysis.”

In comparison, Merck appeared to offer very little in the way of scientific evidence to support their argument.

Merck wrote:

“At Science Day, Merck intends to provide the Court with: (1) an overview of The National Childhood Vaccine Injury Act of 1986 and the National Vaccine Injury Compensation Program, and their impact on the present litigation; (2) background information about the development and approval of vaccines and, specifically, Gardasil, in the United States; and (3) a detailed review of the extensive safety data that established and has continually reaffirmed the safety profile of Gardasil.”

They continued with what appeared to be an attempt to divert the Judge’s attention away from the science by switching the focus onto the Plaintiff’s unfortunate delay in obtaining a diagnosis:

“Although plaintiff alleges a moving target of injuries and purportedly related symptoms, Merck’s Science Day presentations will address the three on which plaintiff currently seems most focused; autoimmune diseases, demyelinating diseases, and Postural Orthostatic Tachycardia Syndrome (“POTS”). A preview of the data concerning Gardasil and these conditions is set forth herein.”

This, in our opinion, failed to address the main points of the case that had been put forward by the Plaintiff and we found it extraordinary, that given this unique opportunity, Merck offered the Judge very little in the way of scientific evidence.

In fact, throughout Merck’s submission, instead of presenting the court with evidence from the Phase 1,2,3 and 4, pre-licensing vaccination trials, that should have preceded the vaccination coming onto the market, Merck appeared to rely heavily on post-marketing evidence from the VAERS website, the CDC, the FDA and other similar organizations.

Furthermore, instead of producing any real science as one would expect, Merck chose to use part of their unique opportunity, to discredit SaneVax Inc, an organization dedicated to providing the public with scientific facts and evidence behind vaccination safety.

Another interesting point that we discovered on reading Merck’s scientific day submission, was that their submission contained a large amount of information that appeared to focus on proving that Gardasil did not cause the teenager’s condition, instead of concentrating on the task at hand.

It will be interesting to see the final outcome of this case and we wish the family and their attorney, every success in their endeavour to get justice for this young lady’s injuries.

To learn more about the underreported harms of HPV vaccine, view our database on the topic here. To learn about the unintended, adverse effects of vaccinations in general, view our database on the topic here.

Christina was born and educated in London, U.K. After taking an A Level in Psychology and a BTEC in Learning Support, Ms. England spent many years researching vaccines and adverse reactions. She gained a Higher National Diploma in Journalism and Media Studies and in 2016 she gained a BA Hons degree in Literature & Humanities. She currently writes for VacTruth, Health Impact News, GreenMedInfo, The Liberty Beacon, Vaccine Impact and Medical Kidnap on immunisation safety and efficacy. She has co-authored the book, Shaken Baby Syndrome or Vaccine Induced Encephalitis – Are Parents Being Falsely Accused? with Dr. Harold Buttram and Vaccination Policy and the UK Government: The Untold Truth with Lucija Tomljenovic PhD, which are sold on Amazon. Websites: Profitable Harm, Carers Against Medical Injustice

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff. “© [April 17, 2018] GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here http://www.greenmedinfo.com/greenmed/newsletter.”

_____________

For more:

http://

MERCK’S DIRTY LITTLE SECRET – BY DR. SUZANNE HUMPHRIES

Category:

Activism, vaccines

Italian Lab Shut Down – About to Testify About Vaccine Contamination & Damage

https://www.healthnutnews.com/world-renowned-scientists-have-their-lab-shut-down-after-troublesome-vaccine-discovery/

World renowned scientists have their lab shut down after troublesome vaccine discovery

By Erin Elizabeth – April 25, 2018

Two Italian researchers who found nanoparticles to be polluting nearly all our vaccines, recently had their home raided by the Italian police and all digital assets including laptops, computers, and flash-drives- basically, years of work and research- taken.

Why? Because one of the scientists, Mrs. Gatti, was about to testify in parliament about vaccine damage.

America’s Vaccine Civil War: Baylor doctor attacks mothers of vaccine damaged children in attempt to silence them

Back in the 90’s, “Dr. Antonietta Gatti discovered the relationship between micro- and nanoparticles as well as a great number of pathologies: cardiovascular diseases, many forms of cancer, multiple neurological diseases,and autoimmune diseases. She’s taken part in many international research projects, including the pathologies induced by depleted uranium, waste incineration, food polluted with inorganic particles, and more.” ¹ Together with her husband, Dr. Stefano Montanari, they founded a laboratory called Nano-diagnostics for the evaluation of the pathological tissues of patients, presently located at the University of Modena and Reggio Emilia, Italy.

However, because of the current climate of deceit in the mainstream media and medical community, it appears someone wanted to keep her research quiet. (It should be said that Dr. Gatti is the current coordinator of the Italian Institute of Technology’s Project of Nanoecotoxicology, called INESE, a “selected expert” for the FAO/WHO on safety in nanotechnological food, a Member of the NANOTOX Cluster of the European Commission, on the Editorial Board of Journal of Biomaterials Applications, a member of the CPCM of the Italian Ministry of Defense, and the author of a book titled “Nanopathology: The health impact of nanoparticles.” In other words, she’s no slouch.)

James Grundvig via the World Mercury Project described what happened:

“Because Gatti and Montanari had taken their research of nanodust and nanoparticles, from in-vivo (performed in a living organism) and in-vitro (performed in a test tube) to what unseen contamination might reside in vaccines in 2016, they came under the microscope of the United States, European, and Italian authorities. They had touched the third rail of medicine. They had crossed the no-go zone with the purported crime being scientific research and discovery. By finding nano-contamination in random vaccines, Gatti and Montanari revealed, for the first time, what no one knew: Vaccines had more than aluminum salts adjuvants, Polysorbate-80, and other inorganic chemicals in them, they also harbored stainless steel, tungsten, copper, and other metals and rare elements that don’t belong in shots given to fetuses, pregnant women, newborns, babies and toddlers developing their lungs, immune and nervous systems.”¹

The scientists work, published in January of 2017 and titled, New Quality‐Control Investigations on Vaccines: Micro‐ and Nanocontamination, hit a nerve.

At that moment, what should have immediately happened was an investigation. What should have happened was the halting of the vaccine schedule. Big Pharma should have been required to deal with the information gathered. But it never did.

Nanoparticles are very small bits of matter that can enter into the human body, to the destruction of human health, “These nano particles are produced by waste incinerators, car traffic, and many other different ways. Because they float in the air, we can inhale them, which means they enter our lungs and then enter into the blood within minutes. This leads to a number of problems. These particles are carried by the blood to every district of the body…When they enter into the tissues, the body cannot get rid of them, and so those particles stay there forever and are the cause of various diseases we see today.”¹

Regulators remain indifferent to unsafe levels of aluminum in vaccines

Please take time to watch the video below as they explain how they’ve been analyzing and studying vaccines for the past 15 years:

Sadly, this the current climate we live in. As we continue to learn new things that counter what we’ve always known to be “truth,” the old guard remains willing to do whatever it takes to silence truth. Even commit fraud. Or kill. Or raid a scientists house to try and scare them from speakig the truth.

“In 2016, a group of scientists at the CDC named SPIDER (Scientists Preserving Integrity, Diligence and Ethics), put out a list of complaints in the form of a letter to the CDC’s Chief of Staff, saying in part, “It appears that our mission is being influenced and shaped by outside parties and rogue interests… and Congressional intent for our agency is being circumvented by some of our leaders. What concerns us most, is that it is becoming the norm and not the rare exception.”¹

Editor in Chief of world’s best known medical journal: Half of all the literature is false

Until that changes, we cannot be afraid to seek doctors, scientists, teachers, politicians and media outlets who will speak and stand for truth.

______________

For more: https://madisonarealymesupportgroup.com/2016/11/29/spider-attacks-cdc/

https://madisonarealymesupportgroup.com/2018/04/06/cdcs-troubling-lack-of-research-ethics/

https://madisonarealymesupportgroup.com/2018/03/21/congress-receives-vaccine-safety-project-details-since-the-cdc-fda-ignore-their-own-data-and-proclaim-vaccines-do-not-cause-autism/

https://madisonarealymesupportgroup.com/2017/10/15/vaccines-and-retroviruses-a-whistleblower-reveals-what-the-government-is-hiding/

https://madisonarealymesupportgroup.com/2018/03/01/vaccines-could-contribute-to-disease-epidemics-due-to-retrovirus-contamination/

Category:

Activism, vaccines

Comparative Diets to Address Chronic Inflammation

http://www.thevaccinereaction.org/2018/04/comparative-diets-to-address-chronic-inflammation/

Comparative Diets to Address Chronic Inflammation

by Kate Raines

Published April 14, 2018

The following is the first half of a two-part article on nutrition that addresses chronic inflammation.

One of the hallmarks of many chronic diseases and disorders is unresolved inflammation in the body. Chronic inflammation can develop when the immune system’s normal inflammatory response to an implied threat continues unabated rather than turning off once the threat is gone.¹

Chronic inflammation is a common link among autoimmune disorders like rheumatoid arthritis, lupus and multiple sclerosis; in cardiovascular disorders that lead to heart attacks and strokes; in neurological disorders such as Alzheimer’s, Parkinson’s and epilepsy; and in mental disorders such as depression and schizophrenia.¹Vaccination has been reported to trigger the development of autoimmune disorders associated with chronic inflammation.²

Infections and Vaccination: Two Different Kinds of Inflammatory Responses and Immunity

Infections and vaccines stimulate different kinds of inflammatory responses in the body to produce antibodies that confer two different kinds of immunity. Naturally acquired active immunity is attained after a person experiences a viral or bacterial infection and the body mounts an inflammatory response to stimulate the production of antibodies and confers long lasting natural immunity. Artificially acquired immunity, which is not identical to naturally acquired immunity, is attained when a person receives a vaccine and the body mounts an inflammatory response to produce antibodies and confers temporary immunity. Booster doses of vaccines to re-stimulate inflammatory responses are often given to lengthen artificial vaccine acquired immunity.³

Depending upon various genetic, biological and environmental risk factors, some people do not resolve inflammation either after an infection or vaccination and can develop chronic inflammation in the body that leads to chronic health problems.⁴⁵In addition to lab altered viruses and bacteria, there are many recognized toxins in childhood vaccines that either singly or in combination cause inflammation in the brain and other parts of the body, including mercury, aluminum, formaldehyde, MSG, antibiotics, polyethylene glycol (antifreeze), squalene, virus like particles and adventitious agents.⁶⁷

Acute inflammation is easy to recognize: heat, swelling, pain and redness at the site of injury or infection. Chronic inflammation is not quite so obvious, but there are common symptoms that indicate its presence. Some of the most frequently reported include headaches and brain fog, bloating and other digestive problems, joint pain, rashes, fatigue, weight gain, gum disease and mood issues⁸—many signs familiar to parents of autistic and/or vaccine-injured children.⁹

Diets Address Chronic Inflammation in Vaccine-Injured Children

The childhood vaccine schedule used in the U.S. has been questioned as a potential factor in the development of inflammatory chronic brain and immune system disorders in children.¹⁰

It is an unfortunate fact that those who question the safety of vaccines often “come to the table” following a firsthand experience with a vaccine reaction… in other words, too late to avoid the potentially devastating impact such a reaction can have on their own life or the life of their child. Since conventional medicine rarely acknowledges the connection between vaccination and chronic brain and immune disorders in children, it can be difficult to know where to turn after a vaccine reaction has occurred and there is often lag time before parents find a supportive network. In the search for healing, one of the first avenues explored by parents and doctors specializing in biomedical and holistic health interventions involves nutrition therapy.

Diet is among the most basic of approaches to addressing chronic inflammation. The connection between diet and the risk for developing inflammatory disorders has been recognized for at least 50 years, though studies have been inconclusive about the role played by specific foods and nutrients.¹¹ Nevertheless, harnessing the power of food often can help counteract a chronic inflammatory process and improve some of the related symptoms.

Dietary Fundamentals for Reducing Inflammation

With all the “named” diets available, it can be daunting to decide which direction to turn. Most anti-inflammatory diets share certain basic tenets: avoid sugar and processed foods; stay away from refined flour, wheat, white foods like pasta, rice and bread; and eliminate unhealthy fats. Foods that are often recommended to reduce inflammation in the body are fresh fruits, dark green leafy vegetables, high-quality proteins like cold-water fish, and healthy fats. Some nutritionists suggest that the so-called nightshade foods, which include tomatoes, eggplant, peppers, goji berries and white potatoes, may trigger inflammation in some people,⁹ and commercial milk products may also cause inflammation in people who are sensitive to lactose or milk proteins.¹¹

Food additives, including dyes, preservatives and artificial flavorings and sweeteners, and high-fructose corn syrup have been pinpointed as problematic for many children with autism spectrum disorders (ASD)¹² and some nutritionists suggest avoiding them when trying to reduce systematic inflammation through dietary changes.

The Difference Is in the Details

Some of the most well known diets that surface in an online search for foods that fight inflammation include: the Gut and Psychology Syndrome (GAPS), Paleo, Mediterranean, Atkins, DASH, TLC, Mayo Clinic, Weight Watchers, Raw Food, Keto, The Zone, Whole30, Autoimmune Protocol, Dr. Hyman’s Detox and Dukan…to name just a few. The annual U.S. News & World Report review of dietary rankings¹³ and other reviews¹⁴of current diet trends can provide an overview for understanding different dietary approaches.

What Do the Experts Say?

The choice of an “anti-inflammatory” diet that limits foods, which have been identified as “pro-inflammatory,” depends on consideration of individual factors, such as specific food sensitivities, personal taste preferences, or the simple desire to try a dietary regimen that sounds interesting.

According to Harvard University’s HealthWatch, “Choose the right foods, and you may be able to reduce your risk of illness. Consistently pick the wrong ones, and you could accelerate the inflammatory disease process.”¹⁵ Included in the HealthWatch list of pro-inflammatory foods that should be avoided to reduce inflammation include:

Refined carbohydrates, such as white bread and pastries
French fries and other fried foods
Soda and other sugar-sweetened beverages
Red meat (burgers, steaks) and processed meat (hot dogs, sausage)
Margarine, shortening, and lard

Anti-inflammatory foods include:

Tomatoes
Olive oil
Green leafy vegetables, such as spinach, kale, and collards
Nuts like almonds and walnuts
Fatty fish like salmon, mackerel, tuna, and sardines
Fruits such as strawberries, blueberries, cherries, and oranges

__________________

For More: https://madisonarealymesupportgroup.com/2018/02/03/do-these-popular-diets-make-you-nutrient-deficient/

https://madisonarealymesupportgroup.com/2016/05/25/nutritional-video/

https://madisonarealymesupportgroup.com/2017/11/24/feel-helplessly-predestined-for-disease-listen-to-this/ In this talk Cyndi O’Meara discusses challenges with wheat.

https://madisonarealymesupportgroup.com/2017/05/20/minding-your-mitochondria/ Diagnosed with MS, Dr. Terry Wahls received the best standard medicine had to offer. After declining to the point of being in a wheel chair, she took matters into her own hands and learned how to properly fuel her body. Using the lessons she learned at the subcellular level, she used diet to cure her MS and get out of her wheelchair.

https://madisonarealymesupportgroup.com/2018/04/04/more-about-healing-from-mcas/

Category:

Activism, Autism, diet and nutrition, Gut Health, Inflammation, Lyme, Lyme Vaccine, vaccines

VL15 Lyme Vaccine – Another Fraud?

http://dermagicexpress.blogspot.com/2017/06/new-vaccine-vl15-for-lyme-disease-nueva.html?m=1 by Dr. Jose Lapenta

Hello friends of the DERMAGIC EXPRESS network brings you another hot topic today with respect to LYME DISEASE or CHRONIC ERYTHEMA MIGRANS ….NEW VACCINE VL15 FOR LYME DISEASE … ANOTHER FRAUD?

The first thing I will remind you, once again, is that in the year 1998 the FDA approved the LYMErix VACCINE to be used against this disease, based on”TARGET” or “DIANA” the proteins of Surface of the BORRELIA BURGDORFERI denominated OspA. The laboratory responsible for marketing the vaccine was GlaxoSmithKline (GSK).

1,400,000 doses were released, and the adverse effects reported by VAERS (ADVERSE EFFECTS REPORTING SYSTEM), which I published in the article STORYS OF VICTIMS OF THE VACCINE FOR THE LYME DISEASE here you can read them.

The vaccine resulted in the death of at least 229 people, of whom 43 were SUICIDATED 7 months after receiving the 2nd dose.

The main side effect was ARTHRITIS, especially the patients with HISTOCOMPATIBILITY ANTIGEN CLASS II, HLA DR4, the laboratory omitted this data in the vaccination, ALSO THE VACCINE DETERIORATED the health of the carriers of the DISEASE. The laboratory also omitted this fact.

At the end, the LYMErix vaccine was discontinued in 2002 for three reasons:

1.) SIDE EFFECTS AND DEATHS DIRECTLY OR INDIRECTLY CAUSED.
2.) REJECTION OF THE POPULATION TO THE VACCINE.
3.) DEMANDS TO THE LABORATORY.

And again you’ll be wondering why I’m telling you this HISTORY THAT HAS 15 YEARS OF EVOLUTION. I’ll give you the answer clear and precise !!!!

All this I am explaining to you because throughout these 15 years, THE LYME DISEASE has spread widely in the United States and Europe. In 2008, 440,000 new cases were reported in the United States and 85,000 in Europe. Currently, in 2017, 300,000 new cases are reported annually in the United States according to the CDC (Center for Disease Control and Prevention).

On the other hand, as I already explained, LYME DISEASE, due to the biological characteristics of BORRELIA (SPIROCHETA), which becomes “undetectable” to diagnostic tests, has become a health problem in these countries. An antibiotic treatment costs between $20 and $1000, and INSURANCE COMPANIES DO NOT WANT TO KNOW ABOUT CHRONIC DISEASES, BECAUSE THE COST IS VERY HIGH. Crude reality.

Here comes the GHOST of the LIMErix vaccine and a new FRENCH BIOTECHNOLOGY company, named VALNEVA, who proudly presented on April 11, 2017 at the World Congress on Vaccines, the project of a “NEW” vaccine for LYME DISEASE, called With CODE VL15-101.

The FDA approved on 9 December 2016, the preliminary tests, leaving pending FINAL APPROVAL based on SUCCESS or failure thereof. The study began in 2016 in Europe, Belgium and will be performed this year 2017 in the United States, in 180 healthy people over 40 years (See attached).

HERE I PUT YOU WHAT VALNEVA SAYS ABOUT THE VL15 PROJECT (See attached)===============================================================

“… Valneva’s vaccine candidate is based on OspA, one of the most dominant surface proteins expressed by the bacteria when present in a tick. The target indication for Valneva’s vaccine candidate is the prophylactic active immunization against Lyme disease in children and adults. Valneva’s program is the only active vaccined evelopment program for Lyme disease in the pharmaceutical industry. Valneva intends to initiate a Phase I trial in the US and Europe in 2016 with the primary objectives of evaluating safety and tolerability. Immunogenicity for six OspA serotypes will also be monitored for different dose groups and formulations. Pre-clinical results indicated that Valneva’s vaccine candidate can provide protection against the majority of Borrelia species…”

Excellent project hopefully ALL what they propose and the vaccine be a SUCCESS, but NOW…

HERE ARE THE 2 GREAT LIES SAYS VALNEVA GAVE IN ITS PRESENTATION AT THE WORLD CONGRESS OF VACCINES IN APRIL OF 2017 AND A THIRD THAT I OMITTED: (see attached)
========================================================================

1.) WHEN LYMErix was withdrawn the FDA PANEL concluded that the LIMErix vaccine was not associated with the production of ARTHRITIS. This is false. VAERS REPORT 322 cases of ARTHRALGIA associated with the vaccine. And the development of VACCINE-INDUCED ARTHRITIS in HLA patients HLA DR-4, now called LYME ARTHRITIS.

2.) LYMErix was a SCIENTIFIC “SUCCESS” says valneva in his exposition. This is also FALSE. WHY DOES THE POPULATION REJECT IT? Because of the great side effects !!! Why did the patients wrote to the FDA PRAYING that LYMErix was removed from the market. ? SIMPLY, BECAUSE IT WAS A FAILURE.

3.) WHY DID VALNEVA not mention the patients who were DISABLED FOR EVER by the LYMErix vaccine and the 229 DEATHS I REPORT THE SAME FDA. ?

Did this company forget that THAT THIS VACCINE CAUSED 229 DEATHS, INCLUDING 43 SUICIDES ???? REPORTED BY VAERS (REPORTING SYSTEM FOR ADVERSE EFFECTS OF VACCINES) Read Here.

I’m going to tell you why VALNEVA “OMITTED” these data: THE ANSWER IS SIMPLE AND UNIQUE:

The new vaccine VL15-101 that is being proposed for LYME DISEASE is based on the same immunological concept of LYMErix VACCINE OspA. Surface proteins of BORRELIA BURGORFERI. The rest is history. (see attached)

On the other hand, it is interesting that you know that in your immune system there is the Major Histocompatibility Complex (MHC) and its HLA (Histocompatibility Antigens) Molecules Class I A, B, and C, and CLASS II DR and DQ MOLECULES. This have been studied by geneticists For more than 30 years and numerous DERMATOLOGICAL and NON-DERMATOLOGICAL diseases have been associated with these antigens.

In the case of LYME DISEASE, HLA DR-4 antigen and HLA B-27 have been associated with ARTHRITIS, while other infectious diseases present in a certain person can “detonate” an HLA antigen to express itself and thereby Worsen a PRE-EXISTING illness, or express a NEW ILLNESS.

The big question is this – Are HLA studies in the population affected by LYME DISEASE being done? These studies were done before placing the LYMErix vaccine? They are currently being done with volunteers for the “NEW VACCINE VL15?”.

As a tip I tell you that Australia did a study on 555 dogs looking for BORRELIA BURGDORFERI, and I came to the conclusion that in this area of the planet there is no LYME disease. In Canada they did it in 2013-2014 and it was concluded that BORRELIOSIS is endemic in that country.

On the other hand, it is well known that LYME DISEASE that does not respond well to treatment, becomes CHRONIC and costs are high. AND ALL OF YOU KNOW THAT INSURANCE COMPANIES DO NOT WANT TO PAY.

Then it is easier, to create a new expectation, A NEW VACCINE 15 YEARS AFTER THE FAILURE OF LYMErix, for two important facts:

1.) DISEASE HAS BEEN DISSEMINATED QUICKLY IN THE NORTH HEMISPHERE.
2.) A PREVENTIVE VACCINE IS BETTER, THAN SPENDING MONEY IN LONG TREATMENTS.

Hopefully VALNEVA will do the proper science and not mislead anyone, and the FDA WILL NOT APPROVE THE VACCINE if the proper science is not done. If it passes the tests WELCOME the new one.

Finally I say the following, VACCINE VL15 is in PHASE I, which means that are testing the SAFETY in people, if it overcomes this obstacle, it will come to Phase II, to prove how well it works PREVENTING LYME disease. Then Phase III, to test it in a broader population RANGE and at different doses.

Cost: about $3 billion. As a note, I tell you that 86% DO NOT PASS the TWO FINAL STAGES, AND 94% of drugs tested on ANIMALS do NOT pass HUMAN tests. So VL15 of valneva has a LONG ROAD to go.

And now I ask you? Are you willing to try a VACCINE while being totally healthy that could trigger in you ANY ILLNESS you would never otherwise suffer?

Did you know that in your immunological composition are HISTOCOMPATIBILITY ANTIGENS, (HLA) that by a simple incidence can “TRIGGER” unknow disease?

We will be looking forward to this new project and as always I wish the BEST TO THIS COMPANY THAT TRIES TO DEVELOP a new LYMErix or VL15 for LYME disease.

In the references and attachments the facts …

REFERENCIAS BIBLIOGRAFICAS / BIBLIOGRAPHICAL REFERENCES
========================================================================

1.) Immunogenetic Markers Definition in Latvian Patients with Lyme Borreliosis and Lyme Neuroborreliosis.
2.) Associations of HLA DR and DQ molecules with Lyme borreliosis in Latvian patients.
3.) The genospecies B. burgdorferi s.l., isolated from ticks and from neurological patients with suspected Lyme borreliosis.
4.) [Critical analysis of reference studies on aluminium-based adjuvants toxicokinetics].
5.) Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorder.
6.) Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome.
7.) HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.
8.) Searching for Lyme borreliosis in Australia: results of a canine sentinel study.
9.) Canine infection with Borrelia burgdorferi, Dirofilaria immitis, Anaplasma spp. and Ehrlichia spp. In Canada, 2013-2014.
10.) Aluminum vaccine adjuvants: are they safe?
11.) Lyme Disease Testing by Large Commercial Laboratories in the United States
========================================================================
1.) Immunogenetic Markers Definition in Latvian Patients with Lyme Borreliosis and Lyme Neuroborreliosis.
========================================================================
Kovalchuka L1, Cvetkova S2, Trofimova J3, Eglite J4, Gintere S5, Lucenko I6, Oczko-Grzesik B7, Viksna L8, Krumina A9,10.
Author information
1
Institute of Food Safety, Animal Health and Environment BIOR, Riga LV-1076, Latvia. Lilija.Kovalcuka@bior.lv.
2
Institute of Food Safety, Animal Health and Environment BIOR, Riga LV-1076, Latvia. Svetlana.Cvetkova@bior.lv.
3
Institute of Food Safety, Animal Health and Environment BIOR, Riga LV-1076, Latvia. Julija.Trofimova@bior.lv.
4
Laboratory of Clinical Immunology and Immunogenetic, Riga Stradiņš University, Riga LV-1067, Latvia. Jelena.Eglite@rsu.lv.
5
Department of Family Medicine, Riga Stradiņš University, Riga LV-1067, Latvia. Sandra.Gintere@rsu.lv.
6
Centre for Disease Prevention and Control of Latvia, Riga LV-1005, Latvia. Irina.lucenko@spkc.gov.lv.
7
Department of Infectious Diseases, Medical University of Silesia, 40-055 Katowice, Poland. bgrzesik@hoga.pl.
8
Department of Infectology and Dermatology, Riga Stradiņš University, Riga LV-1006, Latvia. Ludmila.Viksna@rsu.lv.
9
Institute of Food Safety, Animal Health and Environment BIOR, Riga LV-1076, Latvia. Krumina.Angelika@inbox.lv.
10
Department of Infectology and Dermatology, Riga Stradiņš University, Riga LV-1006, Latvia. Krumina.Angelika@inbox.lv.
Abstract
The aim of this study was to determine the human leukocyte antigen (HLA)-DRB1 alleles in two groups of patients in Latvia: patients with Lyme borreliosis and patients with Lyme neuroborreliosis. The study included 216 patients with Lyme borreliosis, 29 patients with Lyme neuroborreliosis and 282 control persons. All surveyed persons were residents of Latvia. The HLA-DR genotyping was performed by polymerase chain reaction- sequence specific primer (PCR-SSP). The predisposition to the Lyme borreliosis is associated with the HLA-DRB1*07, -DRB1*17(03), -DRB1*04, -DRB1*15(02) alleles. The allele -DRB1*11(05), -DRB1*14(06) and -DRB1*13(06) were significantly more frequent in controls. In-group with Lyme neuroborreliosis differences were found for the -DRB1*07 and -DRB1*04 alleles, but only HLA-DRB1*07 allele was statistically significant after Bonferroni correction and associated with Lyme neuroborreliosis in Latvian patients.
========================================================================
2.) Associations of HLA DR and DQ molecules with Lyme borreliosis in Latvian patients.
========================================================================
Kovalchuka L1, Eglite J, Lucenko I, Zalite M, Viksna L, Krumiņa A.
Author information
1
Riga Stradiņš University, Clinical Immunology and Immunogenetic laboratory, Kronvalda Str 9, Riga, Latvia. Lilija.Kovalcuka@rsu.lv
Abstract
BACKGROUND:
Many autoimmune diseases are associated with variants of HLA genes such as those encoding the MHC complex. This correlation is not absolute, but may help in understanding of the molecular mechanism of disease. The purpose of this study was to determine HLA-DR,-DQ alleles in Latvian patients with Lyme borreliosis and control (healthy) persons. Case patients and control subjects were similar in age, gender and ethnic heritage and differed only as regards the presence of Borrelia burgdorferi infection. The study included 25 patients with clinical stage – erythema migrans and 30 control (healthy) persons. HLA genotyping was performed by PCR with sequence-specific primers.
RESULTS:
The results show difference in HLA-DRB1 alleles distribution between patients and control subjects. The frequencies of HLA-DRB1 *04 (OR 11.24; p < 0.007) and HLA-DRB1 *17 (03) (OR 8.05; p < 0.033) were increased in the Lyme disease patients. And the frequency of allele DRB1*13 (OR 0.12; p < 0.017) was lower in Borreliosis patients and higher in control group. But, significant differences in frequencies of HLA-DQ alleles we did not detect.
CONCLUSIONS:
HLA predisposition to Lyme borreliosis appears not to be limited to HLA molecules, but some HLA-DR alleles also have a significant influence, and, may have implications in our understanding of pathogenesis of this disease. In particular, HLA-DRB1*04 and DRB1 *17 (03) may contribute to the Lyme borreliosis development in Latvian population.
========================================================================
3.) The genospecies B. burgdorferi s.l., isolated from ticks and from neurological patients with suspected Lyme borreliosis.
========================================================================
Neuro Endocrinol Lett. 2011;32(4):491-5.
Bazovska S1, Durovska J, Derdakova M, Taragelova V, Pancak J, Zaborska M, Traubner P.
Author information
1
Institute of Epidemiology, Comenius University, Bratislava, Slovakia. sylvia.bazovska@fmed.uniba.sk
Abstract
OBJECTIVE:
Lyme borreliosis (LB) is the most disseminated tick-borne disease in the Northern hemisphere, and infestation with ticks is one of the essential factors influencing transmission of the disease to humans. This work intends to compare the occurrence of borrelia circulating in indigenous ticks and in patients suffering from neurological diseases.
MATERIALS & METHODS:
The total of 660 nymphs and 567 adult ticks from the Bratislava and Košice areas was examined over the years 2001-2004, and the cerebrospinal fluid (CSF) of 82 neurological patients suffering from suspected Lyme borreliosis infection was investigated in the 2007-2009 period, using the polymerase chain reaction method (PCR).
RESULTS:
PCR investigation proved presence of borrelia in 23.3% of the total 1227 ticks; of these, co-infection was found in 2.7% of all ticks. Borrelia garinii (9.9%) and B. valaisaina (9.2%) were the prevalent types. PCR investigation of the CSF samples of 32 patients with clinically diagnosed Lyme borreliosis showed the presence of B. burgdorferi s.l. in 17 cases. Positive results were found also in patients with unclear or different diagnoses. In cases where the genospecies could be identified, B. garinii was most frequently found (8x), followed with B. burgdorferi s.s. (4×) and B. afzelii (3×).
CONCLUSIONS:
The high infestation level of ticks with borrelia, mainly with B. garinii which is the most-often documented borrelia species identified in neurological patients, is indicative of a high risk of this contamination in Slovakia. B. garinii were found also in our neuroborreliosis patients, whereas their proof in the CSF of patients with suspected neuroborreliosis or with a different clinical diagnosis pointed upon their persistence after an infectious experience. However, knowledge of not only the genospecies but also of the genotypes capable of eliciting an invasive disorder would be necessary for better clarification of the relationship between borrelia and their peccant capacity. Identification of the invasive borrelia types circulating in nature, and clarification of the vector vs. human infection incidence relationship is of importance from the aspect of detailed knowledge of the epidemiology of this disease.
========================================================================
4.) [Critical analysis of reference studies on aluminium-based adjuvants toxicokinetics].
========================================================================
Ann Pharm Fr. 2017 May 30. pii: S0003-4509(17)30033-0. doi: 10.1016/j.pharma.2017.04.004. [Epub ahead of print]
[Article in French]
Masson JD1, Crépeaux G2, Authier FJ1, Exley C3, Gherardi RK4.
Author information
1
Inserm U955 E10, centre expert de pathologie neuromusculaire, « Biologie du système neuromusculaire », hôpital Henri-Mondor, faculté de médecine, université Paris-Est-Créteil, 94010 Créteil, France.
2
Inserm U955 E10, centre expert de pathologie neuromusculaire, « Biologie du système neuromusculaire », hôpital Henri-Mondor, faculté de médecine, université Paris-Est-Créteil, 94010 Créteil, France; École nationale vétérinaire d’Alfort, 7, avenue du Général-de-Gaulle, 94700 Maisons-Alfort, France.
3
Aluminium and Silicon Research Group, The Birchall Centre, Lennard-Jones Laboratories, Keele University, ST5 5BG, Staffordshire, Royaume-Uni.
4
Inserm U955 E10, centre expert de pathologie neuromusculaire, « Biologie du système neuromusculaire », hôpital Henri-Mondor, faculté de médecine, université Paris-Est-Créteil, 94010 Créteil, France. Electronic address: romain.gherardi@aphp.fr.
Abstract
We reviewed the three reference toxicokinetic studies commonly used to suggest innocuity of aluminum (Al)-based adjuvants. A single experimental study was carried out using isotopic 26Al (Flarend et al., 1997). This study ignored adjuvant cell capture. It was conducted over a short period of time (28 days) and used only two rabbits per adjuvant. At the endpoint, Al retention was 78% for aluminum phosphate and 94% for aluminum hydroxide, both results being incompatible with quick elimination of vaccine-derived Al in urines. Tissue distribution analysis omitted three important retention sites: the injected muscle, the draining lymph node and bone. Two theoretical studies have evaluated the potential risk of vaccine Al in infants, by reference to the oral Minimal Risk Level (MRL) extrapolated from animal studies. Keith et al., 2002 used a too high MRL (2mg/kg/d), an erroneous model of 100% immediate absorption of vaccine Al, and did not consider renal and blood-brain barrier immaturity. Mitkus et al. (2011) only considered absorbed Al, with erroneous calculations of absorption duration. They ignored particulate Al captured by immune cells, which play a role in systemic diffusion and the neuro-inflammatory potential of the adjuvant. MRL they used was both inappropriate (oral Al vs injected adjuvant) and far too high (1mg/kg/d) with regard to experimental studies of Al-induced memory and behavioral changes. Both paucity and serious weaknesses of these studies strongly suggest that novel experimental studies of Al adjuvants toxicokinetics should be performed on the long-term, including post-natal and adult exposures, to ensure innocuity and restore population confidence in Al-containing vaccines.
========================================================================
5.) Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorder.
========================================================================
Rodriguez N1,2,3, Morer A2,3,4, González-Navarro EA3,5, Gassó P1,3, Boloc D1, Serra-Pagès C3,5,6, Lafuente A1,2,3, Lazaro L2,3,4,7, Mas S1,2,3.
Author information
1
a Dept. Anatomic Pathology, Pharmacology and Microbiology , University of Barcelona , Barcelona , Spain.
2
b Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) , Barcelona , Spain.
3
c Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona , Spain.
4
d Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences , Hospital Clinic de Barcelona , Barcelona , Spain.
5
e Immunology Service , Centre de Diagnostic Biomèdic, Hospital Clínic Dept , Barcelona , Spain.
6
f Dept. Biomedicine , University of Barcelona , Barcelona , Spain.
7
g Psychiatry and Clinical Psychobiology , University of Barcelona , Barcelona , Spain.
Abstract
OBJECTIVE:
The exact aetiology of obsessive-compulsive disorder (OCD) is unknown, although there is evidence to suggest a gene-environment interaction model. Several lines of evidence support a possible role of the immune system in this model.
METHODS:
The present study explores the allele variability in HLA genes of class II (HLA-DRB1, HLA-DQB1) in a sample of 144 early-onset OCD compared with reference samples of general population in the same geographical area.
RESULTS:
None of the 39 alleles identified (allele frequency >1%) showed significant differences between OCD and reference populations. Pooling the different alleles that comprised HLA-DR4 (including DRB1*04:01, DRB1*04:04 and DRB1*04:05 alleles) we observed a significantly higher frequency (X21 = 5.53, P = 0.018; OR = 1.64, 95% CI 1.08-2.48) of these alleles in the early-onset OCD sample (10.8%) than in the reference population (6.8%).
CONCLUSIONS:
Taking into account the role of HLA class II genes in the central nervous system, the results presented here support a role of the immune system in the pathophysiological model of OCD.
========================================================================
6.) Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome.
========================================================================
Eur J Clin Microbiol Infect Dis. 2007 Sep;26(9):611-7.
Seidel MF1, Domene AB, Vetter H.
Author information
Abstract
The symptoms of Lyme borreliosis are similar to those of a variety of autoimmune musculoskeletal diseases. Persistence of complaints is frequently interpreted as unsuccessful antibiotic treatment of Borrelia-associated infections. However, such refractory cases are rare, and re-evaluation of differential diagnoses helps to avoid the substantial risk of long-term antibiotic therapy. In this study, we analyzed patients who presented to our rheumatology unit with previous suspected or diagnosed Lyme borreliosis. Eighty-six patients from a 3.5-year period were evaluated. The mean age of patients was 49.2 +/- 17.2 years; 60% (n = 52) reported a tick bite and 33% (n = 28) an erythema. Forty-seven percent (n = 39) had positive enzyme-linked immunoassay results and Western blots (Mikrogen, Martinsried, Germany). All but 12 patients had already received antibiotic treatment previously. Nine percent (n = 8) had ongoing or recent Lyme borreliosis. Twenty-nine percent (n = 25) showed clinical symptoms and radiographic changes compatible with degenerative disorders of the cervical and/or lumbar spine. These patients were significantly older when compared to the other patients (59.3 +/- 13.7 years vs 46.1 +/- 17.2 years, p = 0.001). Seventeen percent (n = 16) had arthropathies related to psoriasis or rheumatoid arthritis. Twelve percent (n = 10) were positive for the HLA B27 antigen. Other diseases were less frequent. Six patients (7%) could not be diagnosed conclusively, and four of these patients had negative Borrelia immunoassay results. In conclusion, Borrelia-associated diseases were rare in this study. Differential diagnoses helped to initiate a successful disease-specific therapeutic strategy.
========================================================================
7.) HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.
========================================================================
Clin Microbiol Rev. 2004 Apr;17(2):348-69.
Colmegna I1, Cuchacovich R, Espinoza LR.
Author information
1
Section of Rheumatology, Department of Medicine, LSU Health Science Center, New Orleans, Louisiana 70112, USA.
Abstract
Current evidence supports the concept that reactive arthritis (ReA) is an immune-mediated synovitis resulting from slow bacterial infections and showing intra-articular persistence of viable, non-culturable bacteria and/or immunogenetic bacterial antigens synthesized by metabolically active bacteria residing in the joint and/or elsewhere in the body. The mechanisms that lead to the development of ReA are complex and basically involve an interaction between an arthritogenic agent and a predisposed host. The way in which a host accommodates to invasive facultative intracellular bacteria is the key to the development of ReA. The details of the molecular pathways that explain the articular and extra-articular manifestations of the disease are still under investigation. Several studies have been done to gain a better understanding of the pathogenesis of ReA; these constitute the basis for a more rational therapeutic approach to this disease.
Reactive arthritis (ReA) is defined as a sterile synovitis developing after a distant infection, usually in the genitourinary or gastrointestinal tract. The detection of microbial components (microbial DNA and RNA) in the joints of patients with ReA has led to the reconsideration of this definition (59). Currently, ReA is better defined as an immune-mediated synovitis resulting from slow bacterial infections and showing intra-articular persistence of viable nonculturable bacteria and/or immunogenetic bacterial antigens synthesized by metabolically active bacteria residing in the joint and/or elsewhere in the body. A classification into HLA-B27-associated and nonassociated forms has also been proposed. Post-streptococcal, Lyme, and viral arthritis are HLA-B27 nonassociated and should be described as distinct entities under the general heading of “infection-related arthritides.”
This article focuses on HLA-B27-associated ReA. This form of ReA belongs to the group of spondyloarthropathies (SpA), is triggered by bacteria (which enter the body through the mucosal surfaces) from the genera Campylobacter, Chlamydia, Salmonella, Shigella, and Yersinia, and is clinically associated with oligoarthritis of the lower limbs and sometimes with urethritis and conjunctivitis.
========================================================================
8.) Searching for Lyme borreliosis in Australia: results of a canine sentinel study.
========================================================================
Parasit Vectors. 2017 Mar 13;10(1):114. doi: 10.1186/s13071-017-2058-z.
Irwin PJ1,2, Robertson ID3, Westman ME4, Perkins M5, Straubinger RK6.
Author information
1
Vector and Water-Borne Pathogen Research Group, School of Veterinary and Life Sciences, Murdoch University, Murdoch, Western Australia, 6150, Australia. P.Irwin@murdoch.edu.au.
2
College of Veterinary Medicine, School of Veterinary and Life Sciences, Murdoch University, Murdoch, Western Australia, 6150, Australia. P.Irwin@murdoch.edu.au.
3
College of Veterinary Medicine, School of Veterinary and Life Sciences, Murdoch University, Murdoch, Western Australia, 6150, Australia.
4
Sydney School of Veterinary Science, University of Sydney, Sydney, New South Wales, 2006, Australia.
5
Pymble Veterinary Clinic, Philip Mall, Kendall Street, West Pymble, New South Wales, 2073, Australia.
6
Department of Infectious Diseases and Zoonoses, Bacteriology and Mycology, Ludwig-Maximilians-University Munich, 80539, Munich, Germany.
Abstract
BACKGROUND:
Lyme borreliosis is a common tick-borne disease of the northern hemisphere that is caused by bacterial spirochaetes of the Borrelia burgdorferi (sensu lato) (Bbsl) complex. To date, there has been no convincing evidence for locally-acquired Lyme borreliosis on the Australian continent and there is currently a national debate concerning the nature and distributions of zoonotic tick-transmitted infectious disease in Australia. In studies conducted in Europe and the United States, dogs have been used as sentinels for tick-associated illness in people since they readily contact ticks that may harbour zoonotic pathogens. Applying this principle, we used a combination of serological assays to test dogs living in tick ‘hot spots’ and exposed to the Australian paralysis tick, Ixodes holocyclus, for evidence of exposure to B. burgdorferi (s.l.) antigens and other vector-borne pathogens.
RESULTS:
Altogether, 555 dogs from four demographic groups were recruited into this study. One dog had evidence of exposure to Anaplasma spp. but no other dog was positive in screening tests. A total of 122 dogs (22.0%) had a kinetic ELISA (KELA) unit value > 100, and one dog with a high titre (399.9 KELA units) had been vaccinated against B. burgdorferi (sensu stricto) before travelling to Australia. Older dogs and those with a history of tick paralysis were significantly more likely to have a KELA unit value > 100. Line immunoassay analysis revealed moderate-to-weak (equivocal) bands in 27 (4.9%) dogs.
CONCLUSIONS:
Except for a single dog presumed to have been exposed to Anaplasma platys, infection with Anaplasma spp. B. burgdorferi (s.l.), Ehrlichia spp., and Dirofilaria immitis, was not detected in the cohort of Australian dogs evaluated in this study. These results provide further evidence that Lyme borreliosis does not exist in Australia but that cross-reacting antibodies (false positive results) are common and may be caused by the transmission of other tick-associated organisms.
========================================================================
9.) Canine infection with Borrelia burgdorferi, Dirofilaria immitis, Anaplasma spp. and Ehrlichia spp. In Canada, 2013-2014.
========================================================================
Parasit Vectors. 2017 May 19;10(1):244. doi: 10.1186/s13071-017-2184-7.
Herrin BH1, Peregrine AS2, Goring J3, Beall MJ3, Little SE4.
Author information
1
Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, USA. brian.h.herrin@okstate.edu.
2
Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
3
IDEXX Laboratories, Inc, Westbrook, ME, USA.
4
Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, USA.
Abstract
BACKGROUND:
Canine test results generated by veterinarians throughout Canada from 2013-2014 were evaluated to assess the geographical distribution of canine infection with Borrelia burgdorferi, Dirofilaria immitis, Ehrlichia spp., and Anaplasma spp.
METHODS:
The percent positive test results of 115,636 SNAP® 4Dx® Plus tests from dogs tested were collated by province and municipality to determine the distribution of these vector-borne infections in Canada.
RESULTS:
A total of 2,844/115,636 (2.5%) dogs tested positive for antibody to B. burgdorferi. In contrast, positive test results for D. immitis antigen and antibodies to Ehrlichia spp. and Anaplasma spp. were low, with less than 0.5% of dogs testing positive for any one of these three agents nationwide. Provincial seroprevalence for antibodies to B. burgdorferi ranged from 0.5% (Saskatchewan)-15.7% (Nova Scotia); the areas of highest percent positive test results were in proximity to regions in the USA considered endemic for Lyme borreliosis, including Nova Scotia (15.7%) and Eastern Ontario (5.1%). These high endemic foci, which had significantly higher percent positive test results than the rest of the nation (P < 0.0001), were surrounded by areas of moderate to low seroprevalence in New Brunswick (3.7%), Quebec (2.8%), and the rest of Ontario (0.9%), as well as northward and westward through Manitoba (2.4%) and Saskatchewan (0.5%). Insufficient results were available from the westernmost provinces, including Alberta and British Columbia, to allow analysis.
========================================================================
10.) Aluminum vaccine adjuvants: are they safe?
========================================================================
Curr Med Chem. 2011;18(17):2630-7.
Tomljenovic L1, Shaw CA.
Author information
1
Neural Dynamics Research Group, Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, V5Z 1L8, Canada. lucijat77@gmail.com
Abstract
Aluminum is an experimentally demonstrated neurotoxin and the most commonly used vaccine adjuvant. Despite almost 90 years of widespread use of aluminum adjuvants, medical science’s understanding about their mechanisms of action is still remarkably poor. There is also a concerning scarcity of data on toxicology and pharmacokinetics of these compounds. In spite of this, the notion that aluminum in vaccines is safe appears to be widely accepted. Experimental research, however, clearly shows that aluminum adjuvants have a potential to induce serious immunological disorders in humans. In particular, aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences. In our opinion, the possibility that vaccine benefits may have been overrated and the risk of potential adverse effects underestimated, has not been rigorously evaluated in the medical and scientific community. We hope that the present paper will provide a framework for a much needed and long overdue assessment of this highly contentious medical issue.
========================================================================
11.) Lyme Disease Testing by Large Commercial Laboratories in the United States
========================================================================
source: academic.oup.com/cid/article-lookup/doi/10.1093/cid/ciu397(www)
Alison F. Hinckley Neeta P. Connally James I. Meek Barbara J. Johnson Melissa M. Kemperman Katherine A. Feldman Jennifer L. White Paul S. Mead
Clin Infect Dis (2014) 59 (5): 676-681.
Published: 30 May 2014
Large commercial laboratories in the United States were surveyed to determine Lyme disease testing frequency, practices, and results. Approximately 3.4 million tests were conducted in 2008; 62% in accordance with recommendations. We estimate that 288 000 infections occurred among 2.4 million patients from whom samples were submitted.
Background. Laboratory testing is helpful when evaluating patients with suspected Lyme disease (LD). A 2-tiered antibody testing approach is recommended, but single-tier and nonvalidated tests are also used. We conducted a survey of large commercial laboratories in the United States to assess laboratory practices. We used these data to estimate the cost of testing and number of infections among patients from whom specimens were submitted.
Methods. Large commercial laboratories were asked to report the type and volume of testing conducted nationwide in 2008, as well as the percentage of positive tests for 4 LD-endemic states. The total direct cost of testing was calculated for each test type. These data and test-specific performance parameters available in published literature were used to estimate the number of infections among source patients.
Results. Seven participating laboratories performed approximately 3.4 million LD tests on approximately 2.4 million specimens nationwide at an estimated cost of $492 million. Two-tiered testing accounted for at least 62% of assays performed; alternative testing accounted for <3% of assays. The estimated frequency of infection among patients from whom specimens were submitted ranged from 10% to 18.5%. Applied to the total numbers of specimens, this yielded an estimated 240 000 to 444 000 infected source patients in 2008.
Discussion. LD testing is common and costly, with most testing in accordance with diagnostic recommendations. These results highlight the importance of considering clinical and exposure history when interpreting laboratory results for diagnostic and surveillance purposes.

________________

For more:

https://madisonarealymesupportgroup.com/2017/09/07/20268/ So …in 1994, the CDC hosted a consensus conference in Dearborn, MI, along with a dozen labs across the country and together they falsified the very definition of Lyme disease by eliminating the neurological, immunosuppressive type which account for 85% of the cases.

If they conveniently ‘determined’ that the 85% group – those with an immunosuppression neurological outcome––simply did NOT exist, then they could claim that their vaccine was 85% effective. With no immunosuppressive, neurological disease to find, then the vaccine would be a hit with the remaining 15% who presented with an arthritic, bad-knee type only. A brilliant marketing scheme at the expense of millions worldwide for the years to come.
You see, you CANNOT create a vaccine for an OspA fungal antigen — the TRUE definition of chronic Lyme. It can’t be done. And the OspA vaccination known as LYMErix caused the same disease from a syringe as it does when you get Lyme disease from a tick bite. LYMErix victim’s immune systems were destroyed by the vaccine because OspA is an endotoxin that causes immunosuppression and subsequent severe neurologic multi-system disease.
So by narrowing the definition and by claiming that only one type of the disease (the bad knee arthritic type) exists, then they could sell a vaccine. Not only that. They were also able to profit by limiting the number of labs that were sanctioned and thereby cornering the market on the patents of a variety of tick borne diseases.
THE FIRST LYME VACCINE WAS A COMPLETE BUST.

https://madisonarealymesupportgroup.com/2017/07/01/pbs-lyme-vaccine/ In a vile cesspool of conflicts of interest are university patent holders, drug companies, and the FDA itself as another patent holder. It generated 40 million dollars before it was yanked. (2008, Drymon)
http://www.yourlawyer.com/topics/overview/lymerix One doctor stated that 21 patients developed severe arthritis after receiving the LYMERIX vaccine. https://madisonarealymesupportgroup.com/2017/01/26/lyme-vaccine-to-be-tested-on-humans/ The biological mechanism hypothesis was that the outer surface protein A (OspA), which was the antigenic component of the LYMErix vaccine, induced autoimmunity in genetically susceptible individuals, including high levels of autoantibody to OspA in their synovial fluid.

Dr. Stricker states:

Another Lyme OspA Vaccine Whitewash
The meta-analysis by Zhao and colleagues comes to the conclusion that “the OspA vaccine against Lyme disease is safe and its immunogenicity and efficacy have been verified.” The authors arrive at this sunny conclusion by excluding 99.6% of published articles that demonstrate potential problems with the OspA vaccine.Furthermore, the authors ignore peer-reviewed studies, FDA regulatory meetings and legal proceedings that point to major problems with OspA vaccine safety (1-3). This whitewash bodes ill for future Lyme vaccine candidates because it fosters disregard for vaccine safety among Lyme vaccine manufacturers and mistrust among potential Lyme vaccinees.

Also, I find it highly intriguing that the push here, and always, is for a vaccine; not a cure, not helping patients with pain, not making care accessible and affordable. Just in creating a new cash-cow for a select few. Patients be damned.

Category:

Activism, Lyme, Lyme Vaccine, vaccines

A Tale of 3 Metals, the Fate of Western Civilization, & What We Can Do About it

https://jameslyonsweiler.com/2018/04/07/a-tale-of-three-metals-and-the-fate-western-civilization/

A Tale of Three Metals and The Fate of Western Civilization

by jameslyonsweiler

1200px-madlhatterbytenniel

Biff: LET’S DIG UP TOXINS, PURIFY THEM, AND INJECT THEM INTO OURSELVES! AND BABIES! AND PREGNANT WOMEN! AND LET’S PUT THEM INTO PAINT THAT WE USE IN OUR HOMES WE LIVE IN, AND PUMP THEM INTO THE AIR WE BREATHE! AND LET’S MAKE SURE THAT THE WATER WE DRINK COMES INTO OUR HOMES IN PIPES THAT LEACH LEAD!
Buff: ARE YOU MAD?
Biff: NO, BUT WE WILL BE!

The Romans drank beverages prepared in lead vessels, and brought spring water into their homes through lead pipes. Lead poisoning undoubtedly hastened the fall of the Roman empire. So when we think about the evidence that we are harming ourselves, and our children, with lead in the water, mercury in the air, mercury in flu vaccines, and aluminum in many other vaccines, one has to wonder: what are the likely effects on society?

African Americans will suffer the most. Due to Vitamin D deficiency, African Americans at northern latitudes can be expected to be most sensitive to toxins because they rely on dietary Vitamin D to drive their cellular detoxification systems. The fix? Measure blood Vitamin D levels, and absent any mutation that would preclude increased doses of Vitamin D, improve brain health via addition Vitamin D supplementation.
Young adults (millenials) will have different sociality, and higher rates of early-age psychological disorders such as schizophrenia. They may also experience higher rates of early age of onset Parkison’s disease, Alzheimer’s disease, and other neurodegenerative diseases. The fix? Filter aluminum out of the water, try silica-rich mineral waters, silica drops, with a preference for sources with the more biologically available silicic acid. In short, detoxify their food, water, and everything in their environment, and more (see below).
Young children with special education needs will tend to be more violent and brain studies will show increased presence of amyloid precursor protein, the kind responsible for Alzheimer’s disease.
There will be a population-wide downward shift in IQ.
There will be a plague of multiple chemical sensitivity.
Academics will be stretched thin and the curriculum dumbed down to the point where schools will have to stop giving grades. When 20% of the class can no longer function academically to take and exam, the rest will be asked to “help” their classmates learn.
Families will become increasingly stressful social units. Divorce rates will skyrocket.
People will become increasingly dependent on the State (Nanny State).
Those most able to withstand the toxic effects of accumulating neurotoxins will become increasingly taxed because their income and property will have to sustain an increasingly demanding medico-government empire.
When they, too, begin to fall apart, the tax base will falter.
Violence will become increasingly common. Those most damaged will tend to kill and injure those who are capable.
America will tear itself apart from within.

This doomsday scenario is not inevitable. So what can we do to prevent this?

Listen to the mothers. They have experience in what works. NIH has avoided real research on neurodevelopment disorders that address neurotoxic metal exposure since the CDC worked so hard to defraud the public on the vaccine/autism link. They gambled, lost, and we now pay the cost.
These solutions must be tested in combinations in clinical studies to insure safety, and also to validate them (if they do help). They must be studied NOW, before it’s too late.

Option 1. Environmental Detoxification. Remove all neotoxins from your home. Use reverse osmosis water filters, and use filtered water for everything – even cooking – because aluminum is used to condition the water coming from the tap. Fluoride is another issue, and your filtration should also remove fluoride. Eat organic foods and nothing out of aluminum containers. Certainly never cook in aluminum pots.

Option 2. Get the Aluminum Out. Consider using high silicic acid mineral water, or adding silicic acid drops to your filtered water to bind any aluminum from food. Other possibilities include malic acid, magnesium, and acetoacetic acid:

Principles of Orthomolecularism. R.A.S. Hemat: “Aluminum can be effectively complexed and excreted with silicon, a complex of malic acid and mg, and acetoacetic acid.”

Precise combinations that work best and are safe are not yet determined. That’s why we need studies.

Doctor Toni Bark, MD informs me that ketogenic diet can also help reduce brain inflammation and reduce the effects of toxic metals from the body and the brain – including the reduction of brain amyloid. And Dr. Richard Frey’s research on intranasal insulin https://academic.oup.com/biomedgerontology/article/71/1/30/2614162 and intranasal deferoxamine https://www.ncbi.nlm.nih.gov/pubmed/28870559 seems very promising for the actual removal of iron and aluminum from the brain. Care should be taken to conduct any such research under the direct care of a physician.

Option 3. Up the Vitamin D3, watch the A, Avoid Folic Acid. Dr. Keith Baggerly, MD, has determined that the FDA flubbed in it recommended daily Vit D intake: https://vitamindwiki.com/Vitamin+D+math+mistakes+made+7+years+ago+–+K+Baggerly+2016-2017 As a result, most Americans are Vit D deficient. Increased Vitamin D3 can be expected to improve many aspects of health by helping our cells properly fold proteins. Vits A and D are antagonistic, and so watch all sources of Vit A and make sure you and your child are not taking in too much Vitamin A. Read The Big Vitamin D Mistake: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541280/ and Grant Genereux’s resources on Vit A toxicity [1] [2].

Much of our population has MTHFR mutations that cause problems with Folic Acid. Moms taking prenatal vitamins should seek methyl folate or folinic acid: https://www.nature.com/articles/mp2016168 instead of folic acid. Children’s vitamins with methyl folate are also available.

Option 5. Reduce Brain Inflammation. Chronic low-grade inflammation is a hallmark of autism. Powerful brain antioxidants include N-acetylcysteine and glutathione. It seems likely that everyone with a brain could benefit from less brain inflammation.

Option 6. Improve the Gut. The commensal (helpful) bacteria in the large intestine can become significantly altered after antibiotic use to treat ear infections, most likely caused by harm from to the immune system from thimerosal. Pro-biotics may help, as will eating organic.

Option 7. Keep This Handy for Bad Head Days. Brain dysfunction from metal-induce excitotoxicity involves high glutmate levels in the brain. Oxaloacetate can reduce blood glutamate levels, allowing the excess glutamate in the brain to spill into the blood. Oxaloacetate is used after stroke to reduce the exitotoxic brain injury. Research is needed to determine if it should be used after vaccination to reduce the incidence of vaccine-induced excitotoxicity. And aluminum should be removed from vaccines because the schedule results in toxic doses in infants.

Option 8. HBOT is HOT. Consider Hyperbaric Oxygen Therapy (HBOT). HBOT can increase de novo neurogenesis. If the brain has suffered a loss of neurons due to toxic exposure, increased neurogenesis – at the right time in development – could ultimately be shown to increase IQ.

Option 9. Avoid Thimerosal. If you choose to use a flu vaccination, ask the doctor for the type of flu shot that does not contain thimerosal.

Option 10. Tell Congress You Want Research Reform.

No studies of the synergistic toxicity of aluminum, lead and mercury have been conducted at doses reflecting the vaccine schedule and daily exposure due to leaching of lead from pipes into homes.

We know which homes have lead pipes. Departments of Health should consider telling parents of children in those homes to avoid exposures to mercury and to aluminum – in other words, to skip vaccines that contain these neurotoxic metals. The children will become more educated, better behaved, make better decisions, commit fewer crimes, and overall have better lives. Toxicity of lead, aluminum and mercury is synergistic.

No studies of the options and combinations of options listed above have been conducted to determine if we could improve overall brain health in children and adults. This research is badly needed. YOU can make it happen.

Make an appointment with your Congressional Representative and ask them to create the Brain Health 2030 initiative designed to reverse the ill effects of the past 30 years of industry and medicine on brains, and on our childrens’ brains. These interventions are not intrusive. Studies could be done also with the Department of Education to determine whether reports of violence decrease, grades increase, drop-out rates decrease if entire SCHOOLS – including administrators – are enrolled in Healthy Brain programs, which could incorporate aspects of mindfulness.

You can join the Neurodevelopment Research Reform group on Facebook where ideas on the Brain Health 2030 initiative are shared. And you can support our efforts to compile the most promising evidence-based approaches to improving brain health by supporting IPAK’s Neurodevelopment Research Reform Initiative.

This article is a call for research reform. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Check with your physician before changing any mode of medical treatment for your child, or yourself.

Madison Area Lyme Support Group

Archive for the ‘vaccines’ Category

Merck Accused of Fraud, Deceit and Negligence in U.S. Gardasil Case

Merck Accused of Fraud, Deceit and Negligence in US Gardasil Case

Merck Accused of Fast Tracking a Vaccine for Financial Gain

Judge Agreed to a Science Day Hearing

What Science Did the Two Sides Present?

MERCK’S DIRTY LITTLE SECRET – BY DR. SUZANNE HUMPHRIES

Italian Lab Shut Down – About to Testify About Vaccine Contamination & Damage

World renowned scientists have their lab shut down after troublesome vaccine discovery

RELATED STORY:

RELATED STORY:

RELATED STORY:

Comparative Diets to Address Chronic Inflammation

Comparative Diets to Address Chronic Inflammation

Infections and Vaccination: Two Different Kinds of Inflammatory Responses and Immunity

Diets Address Chronic Inflammation in Vaccine-Injured Children

Dietary Fundamentals for Reducing Inflammation

The Difference Is in the Details

What Do the Experts Say?

VL15 Lyme Vaccine – Another Fraud?

A Tale of 3 Metals, the Fate of Western Civilization, & What We Can Do About it

A Tale of Three Metals and The Fate of Western Civilization

Search

Archives

Lyme Non-Profits

Lyme Resources

Online Support Groups

Visitors

Top Posts & Pages

Categories